These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7908431)

  • 1. Abecarnil used to treat benzodiazepine withdrawal.
    Emmett-Oglesby MW; Lytle DA; English SA
    Psychopharmacol Ser; 1993; 11():121-31. PubMed ID: 7908431
    [No Abstract]   [Full Text] [Related]  

  • 2. Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal.
    Jung ME; Wallis CJ; Gatch MB; Lal H
    Alcohol; 2000 Jun; 21(2):161-8. PubMed ID: 10963939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
    Prather PL; Rezazadeh SM; Lane JD; Rowan GA; Hooper ML; Lytle DA; Emmett-Oglesby MW; Lal H
    J Pharmacol Exp Ther; 1993 Feb; 264(2):622-30. PubMed ID: 8094750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of anxiolytic action of ondansetron in rats during withdrawal from chronic chlordiazepoxide.
    Rezazadeh SM; Prather PL; Emmett-Oglesby MW; Lal H
    Ann N Y Acad Sci; 1992 Jun; 654():472-3. PubMed ID: 1352955
    [No Abstract]   [Full Text] [Related]  

  • 5. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder.
    Ballenger JC; McDonald S; Noyes R; Rickels K; Woods SW; Patin J; Lydiard B; Garvey M; Cook B; Goodard AW
    Adv Biochem Psychopharmacol; 1992; 47():431-47. PubMed ID: 1354920
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term abecarnil administration produces tolerance and withdrawal signs in the rat.
    Elliot EE; White JM
    Eur J Pharmacol; 2000 Apr; 394(2-3):237-45. PubMed ID: 10771289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal.
    Anton RF; Kranzler HR; McEvoy JP; Moak DH; Bianca R
    Psychopharmacology (Berl); 1997 May; 131(2):123-9. PubMed ID: 9201799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withdrawal from benzodiazepine dependence as a discriminative stimulus.
    Emmett-Oglesby MW; Mathis DA
    NIDA Res Monogr; 1989; 95():284. PubMed ID: 2518133
    [No Abstract]   [Full Text] [Related]  

  • 9. Antagonism of ethanol withdrawal convulsions in Withdrawal Seizure Prone mice by diazepam and abecarnil.
    Crabbe JC
    Eur J Pharmacol; 1992 Oct; 221(1):85-90. PubMed ID: 1360903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of flumazenil in rhesus monkeys treated chronically with chlordiazepoxide.
    France CP; Gerak LR
    Pharmacol Biochem Behav; 1997 Mar; 56(3):447-55. PubMed ID: 9077582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discrimination used to study drug withdrawal.
    Emmett-Oglesby MW; Rowan GA
    NIDA Res Monogr; 1991; (116):337-57. PubMed ID: 1369677
    [No Abstract]   [Full Text] [Related]  

  • 12. Abecarnil, a new beta-carboline, in the treatment of anxiety disorders.
    Aufdembrinke B
    Br J Psychiatry Suppl; 1998; (34):55-63. PubMed ID: 9829018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benzodiazepines: anxiolytic and withdrawal effects.
    Little HJ
    Neuropeptides; 1991 Jul; 19 Suppl():11-4. PubMed ID: 1679209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar effects of ethanol and flumazenil on acquisition of a shuttle-box avoidance response during withdrawal from chronic ethanol treatment.
    Criswell HE; Breese GR
    Br J Pharmacol; 1993 Oct; 110(2):753-60. PubMed ID: 8242248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil.
    Löscher W; Hönack D
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):452-60. PubMed ID: 1352384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flumazenil prevents the development of chlordiazepoxide withdrawal in rats tested in the social interaction test of anxiety.
    Baldwin HA; File SE
    Psychopharmacology (Berl); 1989; 97(3):424-6. PubMed ID: 2497494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic bretazenil produces tolerance to chlordiazepoxide, midazolam, and abecarnil.
    Bronson ME
    Pharmacol Biochem Behav; 1995; 51(2-3):481-90. PubMed ID: 7667373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flumazenil blockade of anxiety following ethanol withdrawal in rats.
    Moy SS; Knapp DJ; Criswell HE; Breese GR
    Psychopharmacology (Berl); 1997 Jun; 131(4):354-60. PubMed ID: 9226737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.